Synthesis and Characterization of Novel Co(III)/Ru(II) Heterobimetallic Complexes as Hypoxia-Activated Iron-Sequestering Anticancer Prodrugs
Molecules · 2024
DOI: 10.3390/molecules29245967 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Tan Ba Tran und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Inorganic & Analytical Chemistry, Faculty of Science & Technology, University of Debrecen, H-4032 Debrecen, Hungary. Hauptthemen laut MEDLINE: Coordination Complexes, Antineoplastic Agents, Prodrugs, Cobalt. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development and Innovation Office of Hungary, Ministry of Culture and Innovation of Hungary, National Research, Development and Innovation Fund.
Abstract (Originalsprache)
Heterobimetallic complexes of an ambidentate deferiprone derivative, 3-hydroxy-2-methyl-1-(3-((pyridin-2-ylmethyl)amino)propyl)pyridin-4(1H)-one (PyPropHpH), incorporating an octahedral [Co(4N)]3+ (4N = tris(2-aminoethyl)amine (tren) or tris(2-pyridylmethyl)amine (tpa)) and a half-sandwich type [(η6-p-cym)Ru]2+ (p-cym = p-cymene) entity have been synthesized and characterized by various analytical techniques. The reaction between PyPropHpH and [Co(4N)Cl]Cl2 resulted in the exclusive (O,O) coordination of the ligand to Co(III) yielding [Co(tren)PyPropHp](PF6)2 (1) and [Co(tpa)PyPropHp](PF6)2 (2). This binding mode was further supported by the molecular structure of [Co(tpa)PyPropHp]2(ClO4)3(OH)·6H2O (5) and [Co(tren)PyPropHpH]Cl(PF6)2·2H2O·C2H5OH (6), respectively, obtained via the slow evaporation of the appropriate reaction mixtures and analyzed using X-ray crystallography. Subsequent treatment of 1 or 2 with [Ru(η6-p-cym)Cl2]2 in a one-pot reaction afforded the corresponding heterobimetallic complexes, [Co(tren)PyPropHp(η6-p-cym)RuCl](PF6)3 (3) and [Co(tpa)PyPropHp(η6-p-cym)RuCl](PF6)3 (4), in which the piano-stool Ru core is coordinated by the (N,N) chelating set of the ligand. Cyclic voltammetric measurements revealed that the tpa complexes can be reduced at less negative potentials, suggesting their capability to be bioreductively activated under hypoxia (1% O2). Hypoxia activation of 2 and 4 was demonstrated by cytotoxicity studies on the MCF-7 human breast cancer cell line. PyPropHpH was shown to be a typical iron-chelating anticancer agent, raising the mRNA levels of TfR1, Ndrg1 and p21. Further qRT-PCR studies provided unambiguous evidence for the bioreduction of 2 after 72 h incubation under hypoxia, in which the characteristic gene induction profile caused by the liberated iron-sequestering PyPropHpH was observed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Inorganic & Analytical Chemistry, Faculty of Science & Technology, University of Debrecen, H-4032 Debrecen, Hungary.
- Department of Pharmacology, Faculty of Pharmacy, University of Debrecen, H-4032 Debrecen, Hungary.
- Department of Physical Chemistry, Faculty of Science & Technology, University of Debrecen, H-4032 Debrecen, Hungary.
ORCID-Profile: Tan Ba Tran, Attila Csaba Bényei, István Lekli, Péter Buglyó
Förderung
- National Research, Development and Innovation Office of Hungary
- Ministry of Culture and Innovation of Hungary
- National Research, Development and Innovation Fund
Zitieren
APA
Tran, T. B., Sipos, É., Bényei, A. C., Nagy, S., Lekli, I., & Buglyó, P. (2024). Synthesis and Characterization of Novel Co(III)/Ru(II) Heterobimetallic Complexes as Hypoxia-Activated Iron-Sequestering Anticancer Prodrugs. Molecules. https://doi.org/10.3390/molecules29245967
Vancouver
Tran TB, Sipos É, Bényei AC, Nagy S, Lekli I, Buglyó P. Synthesis and Characterization of Novel Co(III)/Ru(II) Heterobimetallic Complexes as Hypoxia-Activated Iron-Sequestering Anticancer Prodrugs. Molecules. 2024. doi:10.3390/molecules29245967
BibTeX
@article{Tran2024,
author = {Tran, Tan Ba and Sipos, Éva and Bényei, Attila Csaba and Nagy, Sándor and Lekli, István and Buglyó, Péter},
title = {Synthesis and Characterization of Novel Co(III)/Ru(II) Heterobimetallic Complexes as Hypoxia-Activated Iron-Sequestering Anticancer Prodrugs},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29245967}
}
EUVIMED